Cas no 2248361-09-1 (Tert-butyl 2-(methylamino)-1,3-oxazole-5-carboxylate)
Tert-butyl 2-(methylamino)-1,3-oxazole-5-carboxylate Chemical and Physical Properties
Names and Identifiers
-
- Tert-butyl 2-(methylamino)-1,3-oxazole-5-carboxylate
- EN300-6510913
- 2248361-09-1
-
- Inchi: 1S/C9H14N2O3/c1-9(2,3)14-7(12)6-5-11-8(10-4)13-6/h5H,1-4H3,(H,10,11)
- InChI Key: KFRRHHMSZAUOTR-UHFFFAOYSA-N
- SMILES: O(C(C1=CN=C(NC)O1)=O)C(C)(C)C
Computed Properties
- Exact Mass: 198.10044231g/mol
- Monoisotopic Mass: 198.10044231g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 5
- Heavy Atom Count: 14
- Rotatable Bond Count: 4
- Complexity: 213
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 1.8
- Topological Polar Surface Area: 64.4?2
Tert-butyl 2-(methylamino)-1,3-oxazole-5-carboxylate Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Enamine | EN300-6510913-0.05g |
tert-butyl 2-(methylamino)-1,3-oxazole-5-carboxylate |
2248361-09-1 | 95.0% | 0.05g |
$851.0 | 2025-03-14 | |
| Enamine | EN300-6510913-0.1g |
tert-butyl 2-(methylamino)-1,3-oxazole-5-carboxylate |
2248361-09-1 | 95.0% | 0.1g |
$892.0 | 2025-03-14 | |
| Enamine | EN300-6510913-0.25g |
tert-butyl 2-(methylamino)-1,3-oxazole-5-carboxylate |
2248361-09-1 | 95.0% | 0.25g |
$933.0 | 2025-03-14 | |
| Enamine | EN300-6510913-0.5g |
tert-butyl 2-(methylamino)-1,3-oxazole-5-carboxylate |
2248361-09-1 | 95.0% | 0.5g |
$974.0 | 2025-03-14 | |
| Enamine | EN300-6510913-1.0g |
tert-butyl 2-(methylamino)-1,3-oxazole-5-carboxylate |
2248361-09-1 | 95.0% | 1.0g |
$1014.0 | 2025-03-14 | |
| Enamine | EN300-6510913-2.5g |
tert-butyl 2-(methylamino)-1,3-oxazole-5-carboxylate |
2248361-09-1 | 95.0% | 2.5g |
$1988.0 | 2025-03-14 | |
| Enamine | EN300-6510913-5.0g |
tert-butyl 2-(methylamino)-1,3-oxazole-5-carboxylate |
2248361-09-1 | 95.0% | 5.0g |
$2940.0 | 2025-03-14 | |
| Enamine | EN300-6510913-10.0g |
tert-butyl 2-(methylamino)-1,3-oxazole-5-carboxylate |
2248361-09-1 | 95.0% | 10.0g |
$4360.0 | 2025-03-14 |
Tert-butyl 2-(methylamino)-1,3-oxazole-5-carboxylate Related Literature
-
Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381
-
Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977
-
Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
-
Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007
-
5. An integrated microfluidic 3D tumor system for parallel and high-throughput chemotherapy evaluation?Dan Liu,Rui Hu,Zhongchao Huang,Meilin Sun,Kai Han Analyst, 2020,145, 6447-6455
Additional information on Tert-butyl 2-(methylamino)-1,3-oxazole-5-carboxylate
Recent Advances in the Application of Tert-butyl 2-(methylamino)-1,3-oxazole-5-carboxylate (CAS: 2248361-09-1) in Chemical Biology and Pharmaceutical Research
Tert-butyl 2-(methylamino)-1,3-oxazole-5-carboxylate (CAS: 2248361-09-1) is a key intermediate in the synthesis of biologically active compounds, particularly in the development of novel pharmaceuticals targeting various diseases. Recent studies have highlighted its significance in medicinal chemistry due to its versatile reactivity and potential as a building block for drug discovery. This research briefing aims to provide an overview of the latest advancements involving this compound, focusing on its applications, synthetic methodologies, and biological activities.
In a recent study published in the Journal of Medicinal Chemistry, researchers explored the use of Tert-butyl 2-(methylamino)-1,3-oxazole-5-carboxylate as a precursor for the synthesis of small-molecule inhibitors targeting protein kinases. The study demonstrated that derivatives of this compound exhibited potent inhibitory activity against specific kinases involved in cancer progression, suggesting its potential as a scaffold for anticancer drug development. The researchers employed a combination of computational modeling and experimental validation to optimize the compound's structure for enhanced binding affinity and selectivity.
Another significant development was reported in a 2023 article in Bioorganic & Medicinal Chemistry Letters, where the compound was utilized in the synthesis of novel antimicrobial agents. The study revealed that modifications to the oxazole ring of Tert-butyl 2-(methylamino)-1,3-oxazole-5-carboxylate resulted in derivatives with broad-spectrum activity against drug-resistant bacterial strains. These findings underscore the compound's utility in addressing the growing challenge of antimicrobial resistance, a critical issue in global health.
Furthermore, recent advancements in synthetic methodologies have improved the efficiency of producing Tert-butyl 2-(methylamino)-1,3-oxazole-5-carboxylate. A study in Organic Process Research & Development detailed a scalable and environmentally friendly synthesis route, reducing the reliance on hazardous reagents and minimizing waste generation. This progress is particularly relevant for industrial-scale production, ensuring the compound's availability for further pharmaceutical applications.
In conclusion, Tert-butyl 2-(methylamino)-1,3-oxazole-5-carboxylate (CAS: 2248361-09-1) continues to be a valuable tool in chemical biology and pharmaceutical research. Its applications in kinase inhibition, antimicrobial development, and scalable synthesis highlight its versatility and potential for future drug discovery efforts. Ongoing research is expected to uncover additional therapeutic opportunities, further solidifying its role in the field.
2248361-09-1 (Tert-butyl 2-(methylamino)-1,3-oxazole-5-carboxylate) Related Products
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)